• Profile
Close

Adjuvant chemotherapy is associated with improved survival for late-stage salivary squamous cell carcinoma

The Laryngoscope Mar 24, 2019

Cheraghlou S, et al. - In treating early- and late-stage salivary squamous cell carcinoma (SCC), researchers determined the outcomes correlated with the use of adjuvant radiotherapy and chemoradiotherapy. The study sample consisted of 2,285 of surgically resected adult salivary SCC diagnosed in the National Cancer Database between 2004 and 2014. According to this retrospective study, adding chemotherapy to the late-stage adjuvant therapy (either chemoradiotherapy or radiotherapy alone) of salivary SCC patients might lead to improved long-term survival. Expanded use of adjuvant therapy can also improve patient outcomes for early-stage disease.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay